MedTrace Logo

Intra-articular Glucocorticoid Treatment of the Elbow

NCT00972530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-03-14

Study results available
· View outcomes & findings →

Summary

BACKGROUND: Intra-articular glucocorticoid injections are frequently used to relieve symptoms of arthritis. Postinjection rest has been shown to improve the outcome of knee joint injections, but not for wrist injections. Consequently, different joints respond differently on postinjection regimens.

OBJECTIVES: To investigate whether better treatment results might be achieved of post-injection rest following intra-articular glucocorticoid treatment for elbow synovitis.

METHODS: 90 patients with rheumatoid arthritis (RA) and elbow synovitis were treated with 20 mg intra-articular triamcinolone hexacetonide and randomised to either a 48 hour immobilisation in a triangular sling (n=46) or normal activity without restrictions (n=44). Primary endpoint was relapse of synovitis. In addition, pain, function according to a self assessment questionnaire (PREE) and range of movement were followed for six months.

Conditions

Interventions

BEHAVIORAL

immobilisation in a triangular sling

Intervention group: Immobilisation 48 hours in a triangular sling (mitella) Control group: normal activity without restrictions

Sponsors & Collaborators

  • Meda AB

    collaborator UNKNOWN

  • Region Gävleborg

    lead OTHER

Principal Investigators

  • Tomas Weitoft, MD PhD · Department of Research and Development County Council of Gävleborg/Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00972530 on ClinicalTrials.gov